...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection
【24h】

Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection

机译:用荧光和质谱检测通过超高效液相色谱法测定苯丙氨酸,酪氨酸,色氨酸和Kynurenine的定量分析

获取原文
获取原文并翻译 | 示例
           

摘要

We developed and validated a simple and sensitive ultra-high performance liquid chromatography (UHPLC) method for the analysis of phenylalanine (Phe), tyrosine (Tyr), tryptophan (Trp) and kynurenine (Kyn) in rat plasma. Analytes were separated on Acquity UPLC HSS T3 column (2.1 mm x 50 mm, 1.8 mu m particle size) using a 4 min ammonium acetate (pH 5) gradient and detected by fluorescence and positive ESI mass spectrometry. Sample preparation involved dilution of plasma, deproteinization by trichloroacetic acid and centrifugation. The procedure was validated in compliance with the FDA guideline. The limits of quantification (LOQ) were 0.3 mu M for Kyn and from 1.5 to 3 mu M for Phe, Tyr, Trp. The method showed excellent linearity with regression coefficients higher than 0.99. The accuracy was within the range of 86-108%. The inter-day precision (n = 5 days), expressed as % RSD, was in the range 1-13%. The benefit of using UHPLC is a short analysis period and thus, a very good sample throughput. Using this method, we analyzed plasma samples and detected significant changes of Kyn and Phe in transgenic rat model for tauopathies. (C) 2015 Elsevier B.V. All rights reserved.
机译:我们开发并验证了一种简单敏感的超高效液相色谱(UHPLC)方法,用于分析苯丙氨酸(PHE),酪氨酸(TYR),色氨酸(TRP)和大鼠血浆蛋白质(Kyn)。使用4 min乙酸铵(pH5)梯度,通过荧光和阳性ESI质谱法检测分析物在Acquity UPLC HSS T3柱(2.1mm×50mm,1.8μm,1.8μm粒度)上分离。样品制备涉及稀释血浆,通过三氯乙酸和离心脱蛋白。该程序符合FDA指南验证。定量限制(LOQ)为kyn为0.3μm,对于phe,tyr,trp为1.5至3μm。该方法显示出优异的线性性,回归系数高于0.99。准确性在86-108%的范围内。日常精度(n = 5天)表示为%RSD,在1-13%的范围内。使用UHPLC的益处是一个简短的分析周期,因此是一个非常好的样品吞吐量。使用该方法,我们分析了血浆样品并检测到卫地疗法转基因大鼠模型中Kyn和Phe的显着变化。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号